Skip to content

Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.

Field Trial With Omega-3 Fatty Acid Supplementation for the Prevention of Cognitive Decline in a Very Elderly Population

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01817101
Enrollment
170
Registered
2013-03-22
Start date
2012-01-31
Completion date
2015-12-31
Last updated
2015-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Brief summary

The purpose of this study is to determine whether an omega-3 fatty acid supplementation is effective in the prevention of progressive cognitive decline in elderly people aged 75 years or older.

Detailed description

Participants are residents at three nursing homes in Pamplona (Spain). We assumed that 20% of elderly people have a cognitive decline and we estimated a 5% of cognitive decline in the intervention group. Sample size estimated was 85 participants for each arm, assuming two groups with an alpha of 0.05, 80% power and accounting for 10% of participants lost to follow-up. Repeated measures ANOVA, Cox regression and multiple linear regression analysis will be used for the statistical analysis of data.

Interventions

Gelatine capsule, 1 at each meals (3 per day) during one year

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Elderly people aged 75 years or older * Global Deterioration Scale \< 4 * Capacity to complete the tests

Exclusion criteria

* Neurological, physical or psychiatry conditions, obtained from the medical history, that may have an influence on the cognitive function. * Dementia * History of epilepsy, convulsions

Design outcomes

Primary

MeasureTime frameDescription
Mini Mental State ExaminationSix months / one yearMMSE is a brief questionnaire test that is used to screen for cognitive impairment. A validated test in Spanish will be used: Lobo A. Saza P. Marcos G, Díaz J, De la Cámara C, Ventura T et al: Revalidación y normalización del Mini-Examen Cogniscitivo (primera versión en castellano del Mini-Mental Status Examination) en la población general geriátrica. Med Clin (Barc) 1999;112:767-774.

Secondary

MeasureTime frameDescription
Short Portable Mental Status Questionnaire (SPMSQ)One yearA questionnaire for the assessment of organic brain deficit in elderly patients (Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-41)
Verbal fluency testOne yearCategory verbal fluency test. Rosen W.: Verbal fluency in aging and dementia. J. Clin Neuropsychol 1980;2: 135-146.
Clock-drawing testOne yearA cognitive test that covers a wide range of cognitive function. Battersby, W.S., Bender, M.B., Pollack, M. y Kahn, R.L. Unilateral spatial agnosia (inattention) in patients with cortical lesions. Brain 1956; 79: 68-93.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026